Advisory Committee Information Hotline, 9416-9418 [2010-4258]

Download as PDF 9416 Federal Register / Vol. 75, No. 40 / Tuesday, March 2, 2010 / Notices Karen V. Gregory, Secretary. Committee Information Hotline (the hotline). The hotline provides the public with access to the most current information available on FDA advisory committee meetings. This notice supersedes all previously published announcements of FDA’s Advisory Committee Information Hotline. [FR Doc. 2010–4202 Filed 3–1–10; 8:45 am] BILLING CODE 6730–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES FOR FURTHER INFORMATION CONTACT: Michael F. Ortwerth, Director, Advisory Committee Oversight and Management Staff (HF–4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–1220. Food and Drug Administration [Docket No. FDA–2010–N–0001] Advisory Committee Information Hotline AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that we have revised the Advisory The Advisory Committee Information Hotline can be accessed by dialing 1– 800–741–8138 or 301–443–0572. The advisory committee meeting information and information updates can also be accessed via FDA’s Advisory SUPPLEMENTARY INFORMATION: Committee Internet site at https:// www.fda.gov/AdvisoryCommittees/ default.htm. Each advisory committee is assigned a 10-digit number. This 10-digit number will appear in each individual notice of meeting. The public can obtain information about a particular advisory committee meeting by using the committee’s 10-digit number. Information on the hotline is preliminary and may change before a meeting is actually held. The hotline will be updated when such changes are made. The following is a list of each advisory committee’s 10-digit number to be used when accessing the hotline. The list has been updated to add the newly established advisory committee in the Center for Tobacco called the Tobacco Products Scientific Advisory Committee. Advisory Committee 10-Digit Access Number OFFICE OF THE COMMISSIONER Pediatric Advisory Committee 8732310001 Risk Communication Advisory Committee 8732112560 Science Board to the FDA 3014512603 CENTER FOR BIOLOGICS EVALUATION AND RESEARCH Allergenic Products Advisory Committee 3014512388 Blood Products Advisory Committee 3014519516 Cellular, Tissue & Gene Therapies Advisory Committee 3014512389 Transmissible Spongiform Encephalopathies Advisory Committee 3014512392 Vaccines and Related Biological Products Advisory Committee 3014512391 CENTER FOR DRUG EVALUATION AND RESEARCH 3014512530 Antiviral Drugs Advisory Committee 3014512531 Arthritis Advisory Committee 3014512532 Cardiovascular and Renal Drugs Advisory Committee 3014512533 Dermatologic and Ophthalmic Drugs Advisory Committee 3014512534 Drug Safety and Risk Management Advisory Committee 3014512535 Endocrinologic and Metabolic Drugs Advisory Committee 3014512536 Gastrointestinal Drugs Advisory Committee 3014512538 Nonprescription Drugs Advisory Committee 3014512541 Oncologic Drugs Advisory Committee 3014512542 Peripheral and Central Nervous System Drugs Advisory Committee 3014512543 Pharmaceutical Science & Clinical Pharmacology, Advisory Committee for (formerly Advisory Committee for Pharmaceutical Science) VerDate Nov<24>2008 3014512529 Anti-Infective Drugs Advisory Committee WReier-Aviles on DSKGBLS3C1PROD with NOTICES Anesthetic and Life Support Drugs Advisory Committee 3014512539 15:07 Mar 01, 2010 Jkt 220001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1 Federal Register / Vol. 75, No. 40 / Tuesday, March 2, 2010 / Notices Advisory Committee 9417 10-Digit Access Number Psychopharmacologic Drugs Advisory Committee 3014512544 Pulmonary-Allergy Drugs Advisory Committee 3014512545 Reproductive Health Drugs, Advisory Committee for 3014512537 CENTER FOR FOOD SAFETY AND APPLIED NUTRITION Food Advisory Committee 3014510564 CENTER FOR DEVICES AND RADIOLOGICAL HEALTH Device Good Manufacturing Practice Advisory Committee 3014512398 Medical Devices Advisory Committee comprised of 18 panels) Anesthesiology and Respiratory Therapy Devices Panel 3014512624 Circulatory System Devices Panel 3014512625 Clinical Chemistry and Clinical Toxicology Devices Panel 3014512514 Dental Products Panel 3014512518 Ear, Nose, and Throat Devices Panel 3014512522 Gastroenterology-Urology Devices Panel 3014512523 General and Plastic Surgery Devices Panel 3014512519 General Hospital and Personal Use Devices Panel 3014512520 Hematology and Pathology Devices Panel 3014512515 Immunology Devices Panel 3014512516 Medical Devices Dispute Resolution Panel 3014510232 Microbiology Devices Panel 3014512517 Molecular and Clinical Genetics Panel 3014510231 Neurological Devices Panel 3014512513 Obstetrics-Gynecology Devices 3014512524 Ophthalmic Devices Panel 3014512396 Orthopaedic and Rehabilitation Devices Panel 3014512521 Radiological Devices Panel 3014512526 National Mammography Quality Assurance Advisory Committee 3014512397 Technical Electronic Product Radiation Safety Standards Committee 3014512399 CENTER FOR TOBACCO Tobacco Products Scientific Advisory Committee 8732110002 CENTER FOR VETERINARY MEDICINE Veterinary Medicine Advisory Committee 3014512548 WReier-Aviles on DSKGBLS3C1PROD with NOTICES NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR) Science Advisory Board to NCTR The hotline will provide the most recent information available on upcoming advisory committee meetings, guidance for making an oral presentation during the open public VerDate Nov<24>2008 15:07 Mar 01, 2010 Jkt 220001 3014512559 hearing portion of a meeting, and procedures on obtaining copies of transcripts of advisory committee meetings. Because the hotline will communicate the most current PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 information available about any particular advisory committee meeting, this system will provide interested parties with timely and equal access to such information. The hotline should E:\FR\FM\02MRN1.SGM 02MRN1 9418 Federal Register / Vol. 75, No. 40 / Tuesday, March 2, 2010 / Notices also conserve agency resources by reducing the current volume of inquiries individual FDA offices and employees must handle concerning advisory committee schedules and procedures. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: February 24, 2010. Joanne Less, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2010–4258 Filed 3–1–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health WReier-Aviles on DSKGBLS3C1PROD with NOTICES Submission for OMB Review; Comment Request; Reinstatement of OMB No. 0925–0601/exp. 02/28/2010, Request for Human Embryonic Stem Cell Line To Be Approved for Use in NIH Funded Research SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a reinstatement of approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on September 25, 2009, page 48973 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection unless it displays a currently valid OMB control number. Proposed Collection: Title: Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research. Type of Information Collection Request: Revision, OMB 0925–0601, Expiration Date 02/28/2010, Form Number: NIH 2890. Need and Use of Information Collection: The form is used by applicants to request that human embryonic stem cell lines be approved for use in NIH funded research. Frequency of response: Applicants may submit applications at any time; this request is a one-time submission. Affected Public: Business or other for-profit; Not-for-profit institutions; Federal Government; and State, Local or Tribal Government. Type VerDate Nov<24>2008 15:07 Mar 01, 2010 Jkt 220001 of Respondents: Adult scientific professionals. The annual reporting burden is as follows: Estimated Number of Respondents: 160,135; Estimated Number of Responses per Respondent: 1; Average Burden Hours per Response: 14; and Estimated Total Annual Burden Hours Requested: 2,251,500. The estimated annualized cost to respondents is $78,802,500. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Ms. Mikia Currie, Division of Grants Policy, Office of Policy for Extramural Research Administration, NIH, Rockledge 1 Building, Room 3505, 6705 Rockledge Drive, Bethesda, MD 20892–7974, or call non-toll-free number (301) 435– 0941, or E-mail your request, including your address to: curriem@od.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. Dated: February 25, 2010. Mikia Currie, Office of Policy for Extramural Research Administration, OD, NIH. [FR Doc. 2010–4301 Filed 3–1–10; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: Evaluation of Adolescent Pregnancy Prevention Approaches— Baseline Data Collection. OMB No.: ICRAS: 0970–0360. Description: The Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is proposing a data collection activity as part of the Evaluation of Adolescent Pregnancy Prevention Approaches (PPA). PPA is being undertaken to expand available evidence on effective ways to reduce teen pregnancy. The evaluation will document and test a range of pregnancy prevention approaches in up to eight program sites. Program impacts will be estimated using a random assignment design, involving random assignment at the school, individual, or other level, depending on the program setting. The findings of the evaluation will be of interest to the general public, to policymakers, and to organizations interested in teen pregnancy prevention. This proposed information collection activity focuses on collecting baseline data from a self-administered questionnaire which will be used to perform meaningful analysis to determine significant program effects. Through a survey instrument, respondents will be asked to answer carefully selected questions about demographics and risk and protective factors related to teen pregnancy. As appropriate to each program being evaluated, youth records, performance, and program participation data will also be collected. Respondents: The data will be collected through private, selfadministered questionnaires completed by study participants, i.e. adolescents assigned to a select school or community teen pregnancy prevention program or a control group. Surveys will be distributed and collected by trained professional staff. Youth school records, performance, and program participation data will also be collected from participating schools and organizations, as appropriate to the site. BILLING CODE 4140–01–P PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1

Agencies

[Federal Register Volume 75, Number 40 (Tuesday, March 2, 2010)]
[Notices]
[Pages 9416-9418]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-4258]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]


Advisory Committee Information Hotline

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that we 
have revised the Advisory Committee Information Hotline (the hotline). 
The hotline provides the public with access to the most current 
information available on FDA advisory committee meetings. This notice 
supersedes all previously published announcements of FDA's Advisory 
Committee Information Hotline.

FOR FURTHER INFORMATION CONTACT: Michael F. Ortwerth, Director, 
Advisory Committee Oversight and Management Staff (HF-4), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

SUPPLEMENTARY INFORMATION: The Advisory Committee Information Hotline 
can be accessed by dialing 1-800-741-8138 or 301-443-0572. The advisory 
committee meeting information and information updates can also be 
accessed via FDA's Advisory Committee Internet site at https://www.fda.gov/AdvisoryCommittees/default.htm.
    Each advisory committee is assigned a 10-digit number. This 10-
digit number will appear in each individual notice of meeting. The 
public can obtain information about a particular advisory committee 
meeting by using the committee's 10-digit number. Information on the 
hotline is preliminary and may change before a meeting is actually 
held. The hotline will be updated when such changes are made. The 
following is a list of each advisory committee's 10-digit number to be 
used when accessing the hotline. The list has been updated to add the 
newly established advisory committee in the Center for Tobacco called 
the Tobacco Products Scientific Advisory Committee.

--------------------------------------------------------------------------------------------------------------------------------------------------------
                                              Advisory Committee                                                         10-Digit Access Number
--------------------------------------------------------------------------------------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pediatric Advisory Committee                                                                                    8732310001
--------------------------------------------------------------------------------------------------------------------------------------------------------
Risk Communication Advisory Committee                                                                           8732112560
--------------------------------------------------------------------------------------------------------------------------------------------------------
Science Board to the FDA                                                                                        3014512603
--------------------------------------------------------------------------------------------------------------------------------------------------------
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
--------------------------------------------------------------------------------------------------------------------------------------------------------
Allergenic Products Advisory Committee                                                                          3014512388
--------------------------------------------------------------------------------------------------------------------------------------------------------
Blood Products Advisory Committee                                                                               3014519516
--------------------------------------------------------------------------------------------------------------------------------------------------------
Cellular, Tissue & Gene Therapies Advisory Committee                                                            3014512389
--------------------------------------------------------------------------------------------------------------------------------------------------------
Transmissible Spongiform Encephalopathies Advisory Committee                                                    3014512392
--------------------------------------------------------------------------------------------------------------------------------------------------------
Vaccines and Related Biological Products Advisory Committee                                                     3014512391
--------------------------------------------------------------------------------------------------------------------------------------------------------
CENTER FOR DRUG EVALUATION AND RESEARCH
--------------------------------------------------------------------------------------------------------------------------------------------------------
Anesthetic and Life Support Drugs Advisory Committee                                                            3014512529
--------------------------------------------------------------------------------------------------------------------------------------------------------
Anti-Infective Drugs Advisory Committee                                                                         3014512530
--------------------------------------------------------------------------------------------------------------------------------------------------------
Antiviral Drugs Advisory Committee                                                                              3014512531
--------------------------------------------------------------------------------------------------------------------------------------------------------
Arthritis Advisory Committee                                                                                    3014512532
--------------------------------------------------------------------------------------------------------------------------------------------------------
Cardiovascular and Renal Drugs Advisory Committee                                                               3014512533
--------------------------------------------------------------------------------------------------------------------------------------------------------
Dermatologic and Ophthalmic Drugs Advisory Committee                                                            3014512534
--------------------------------------------------------------------------------------------------------------------------------------------------------
Drug Safety and Risk Management Advisory Committee                                                              3014512535
--------------------------------------------------------------------------------------------------------------------------------------------------------
Endocrinologic and Metabolic Drugs Advisory Committee                                                           3014512536
--------------------------------------------------------------------------------------------------------------------------------------------------------
Gastrointestinal Drugs Advisory Committee                                                                       3014512538
--------------------------------------------------------------------------------------------------------------------------------------------------------
Nonprescription Drugs Advisory Committee                                                                        3014512541
--------------------------------------------------------------------------------------------------------------------------------------------------------
Oncologic Drugs Advisory Committee                                                                              3014512542
--------------------------------------------------------------------------------------------------------------------------------------------------------
Peripheral and Central Nervous System Drugs Advisory Committee                                                  3014512543
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pharmaceutical Science & Clinical Pharmacology, Advisory Committee for (formerly Advisory Committee for         3014512539
 Pharmaceutical Science)
--------------------------------------------------------------------------------------------------------------------------------------------------------

[[Page 9417]]

 
Psychopharmacologic Drugs Advisory Committee                                                                    3014512544
--------------------------------------------------------------------------------------------------------------------------------------------------------
Pulmonary-Allergy Drugs Advisory Committee                                                                      3014512545
--------------------------------------------------------------------------------------------------------------------------------------------------------
Reproductive Health Drugs, Advisory Committee for                                                               3014512537
--------------------------------------------------------------------------------------------------------------------------------------------------------
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
--------------------------------------------------------------------------------------------------------------------------------------------------------
Food Advisory Committee                                                                                         3014510564
--------------------------------------------------------------------------------------------------------------------------------------------------------
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
--------------------------------------------------------------------------------------------------------------------------------------------------------
Device Good Manufacturing Practice Advisory Committee                                                           3014512398
--------------------------------------------------------------------------------------------------------------------------------------------------------
Medical Devices Advisory Committee comprised of 18 panels)
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Anesthesiology and Respiratory Therapy Devices Panel                                                          3014512624
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Circulatory System Devices Panel                                                                              3014512625
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Clinical Chemistry and Clinical Toxicology Devices Panel                                                      3014512514
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Dental Products Panel                                                                                         3014512518
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Ear, Nose, and Throat Devices Panel                                                                           3014512522
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Gastroenterology-Urology Devices Panel                                                                        3014512523
--------------------------------------------------------------------------------------------------------------------------------------------------------
  General and Plastic Surgery Devices Panel                                                                     3014512519
--------------------------------------------------------------------------------------------------------------------------------------------------------
  General Hospital and Personal Use Devices Panel                                                               3014512520
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Hematology and Pathology Devices Panel                                                                        3014512515
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Immunology Devices Panel                                                                                      3014512516
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Medical Devices Dispute Resolution Panel                                                                      3014510232
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Microbiology Devices Panel                                                                                    3014512517
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Molecular and Clinical Genetics Panel                                                                         3014510231
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Neurological Devices Panel                                                                                    3014512513
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Obstetrics-Gynecology Devices                                                                                 3014512524
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Ophthalmic Devices Panel                                                                                      3014512396
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Orthopaedic and Rehabilitation Devices Panel                                                                  3014512521
--------------------------------------------------------------------------------------------------------------------------------------------------------
  Radiological Devices Panel                                                                                    3014512526
--------------------------------------------------------------------------------------------------------------------------------------------------------
National Mammography Quality Assurance Advisory Committee                                                       3014512397
--------------------------------------------------------------------------------------------------------------------------------------------------------
Technical Electronic Product Radiation Safety Standards Committee                                               3014512399
--------------------------------------------------------------------------------------------------------------------------------------------------------
CENTER FOR TOBACCO
--------------------------------------------------------------------------------------------------------------------------------------------------------
Tobacco Products Scientific Advisory Committee                                                                  8732110002
--------------------------------------------------------------------------------------------------------------------------------------------------------
CENTER FOR VETERINARY MEDICINE
--------------------------------------------------------------------------------------------------------------------------------------------------------
Veterinary Medicine Advisory Committee                                                                          3014512548
--------------------------------------------------------------------------------------------------------------------------------------------------------
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Science Advisory Board to NCTR                                                                                  3014512559
--------------------------------------------------------------------------------------------------------------------------------------------------------

    The hotline will provide the most recent information available on 
upcoming advisory committee meetings, guidance for making an oral 
presentation during the open public hearing portion of a meeting, and 
procedures on obtaining copies of transcripts of advisory committee 
meetings. Because the hotline will communicate the most current 
information available about any particular advisory committee meeting, 
this system will provide interested parties with timely and equal 
access to such information. The hotline should

[[Page 9418]]

also conserve agency resources by reducing the current volume of 
inquiries individual FDA offices and employees must handle concerning 
advisory committee schedules and procedures.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: February 24, 2010.
Joanne Less,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-4258 Filed 3-1-10; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.